Search results
Nvidia CEO Jensen Huang says companies will 'still want human' workers as AI grows
Quartz· 1 hour agoThe man behind the chips powering the current artificial intelligence boom doesn’t think the...
5 things to know before the stock market opens Monday
CNBC· 2 hours agoLooking ahead, this week will be filled with more major corporate earnings, key labor data and a...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 6 hours agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Moderna Options Trading: A Deep Dive into Market Sentiment - Moderna (NASDAQ:MRNA)
Benzinga· 7 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna . Looking at options history for Moderna MRNA ...
What Immigrants Bring To America
Forbes· 4 days agoToday we hear echoes of a frightening anti-immigrant rhetoric that has emerged and reemerged often in American history. Let’s call this rhetoric for what...
Moderna Inc [MRNA] Shares Fall
Knox Daily· 2 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc shares valued at $1,550,703 were sold by AFEYAN NOUBAR on ...
2 Top Growth Stocks to Buy Right Now and Hold Forever
Motley Fool via Yahoo Finance· 1 day agoIts drugs are helping patients live better and longer, which in turn extends the life cycle for use...
State’s highest paid CEO reports major drop in compensation - Boston Business Journal
The Business Journals· 3 days agoLast year, Douglas Ingram, the president and CEO of Sarepta Therapeutics (Nasdaq: SRPT), reported...
British patients test world’s first personalised MRNA cancer jab for melanoma
The Independent via Yahoo News· 3 days agoThe “gamechanger” jab works by telling the body to hunt down cancer cells to prevent the deadly...
Moderna Investors Should Beware Patent-Dispute Fallout (NASDAQ:ABUS)
Seeking Alpha· 6 days agoModerna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.